Skip to content

Custom made LLIF artificial bone

Clinical trial on the safety and efficacy of lateral lumbar fusion using a custom-made porous titanium artificial bone

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs052210067
Enrollment
3
Registered
2021-08-19
Start date
2021-11-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative lumbar diseases lumbar spine, degenerative disease

Interventions

Perform lumbar spine surgery using patient-specific artificial bone, which is an unapproved medical device, and follow up for 1 year after surgery.operative intervention

Sponsors

Fujibayashi Shunsuke
Lead Sponsor
G-Cube Co., Ltd.
Collaborator
Kyoto University Incubation Program
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The main complaints are lumbar disc disease, lumbar spondylolisthesis, lumbar spinal canal stenosis, low back pain due to osteoporotic vertebral body fracture, nerve root symptoms, and cauda equina symptoms that do not improve with conservative treatment (physical therapy or drug therapy) for 3 months or longer. Cases for which LLIF surgery is indicated and shape compatibility cannot be obtained with existing cages.

Exclusion criteria

Exclusion criteria: Other spinal lesions such as cervical and thoracic spine disorders that require treatment Systemic autoimmune diseases such as rheumatoid arthritis Complications that are judged to seriously interfere with the execution of clinical trials (uncontrollable diabetes and hypertension, serious heart disease, respiratory disease, etc.) Malignant tumor with no disease period within 5 years Mental illness or psychiatric symptoms that may be difficult to participate in clinical trials Bacterial infectious diseases of clinical problem Diseases that require continuous systemic administration of steroids

Design outcomes

Primary

MeasureTime frame
1)Occurrence of adverse events 2)Improvement of symptoms

Secondary

MeasureTime frame
1)Avoiding autologous iliac bone graft 2)Proper placement of test device 3)Bony union of test device 4)Acquisition and maintenance of spinal alignment

Contacts

Public ContactShunsuke Fujibayashi

Kyoto University hospital

shfuji@kuhp.kyoto-u.ac.jp+81-75-751-3366

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026